Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study

Medical Microbiology and Immunology

Volumn 204, Issue 5, 2015, Pages 585-592

  Idelevich, Evgeny A ^a   Silling, Gerda ^b   Niederbracht, Yvonne ^a   Penner, Hanna ^a   Sauerland, Maria Cristina ^b   Tafelski, Sascha ^c   Nachtigall, Irit ^c   Berdel, Wolfgang E ^b   Peters, Georg ^a   Becker, Karsten ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antimicrobial therapy; Blood culture; Coagulase negative staphylococci; Diagnostics; Febrile neutropenia; PCR; Randomized controlled trial; Staphylococcus aureus; Treatment

Indexed keywords

CASPOFUNGIN; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; POSACONAZOLE; VORICONAZOLE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DISEASE DURATION; DRUG TARGETING; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; FEVER; FUNGUS IDENTIFICATION; HEMATOLOGIC MALIGNANCY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOSIS; NEUTROPENIA; NONHUMAN; OUTCOME ASSESSMENT; PERIPHERAL VEIN; PHARMACEUTICAL CARE; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; AGED; COMPLICATION; HEMATOLOGIC DISEASE; MIDDLE AGED; MOLECULAR DIAGNOSIS; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFECTIVE AGENTS; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84939263826     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-014-0385-7     Document Type: Article

References (31)

1. Penack O, Buchheidt D, Christopeit M, von Lilienfeld-Toal M, Massenkeil G, Hentrich M, Salwender H, Wolf HH, Ostermann H (2011) Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology. Ann Oncol 22:1019–1029
2. Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV (2001) Infections in the neutropenic patient—new views of an old problem. Hematology Am Soc Hematol Educ Program 2001:113–139
3. Sharma A, Lokeshwar N (2005) Febrile neutropenia in haematological malignancies. J Postgrad Med 51(Suppl 1):S42–S48
4. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596
5. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237–1248
6. von Lilienfeld-Toal M, Lehmann LE, Raadts AD, Hahn-Ast C, Orlopp KS, Marklein G, Purr I, Cook G, Hoeft A, Glasmacher A, Stuber F (2009) Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 47:2405–2410
7. Lamoth F, Jaton K, Prod’hom G, Senn L, Bille J, Calandra T, Marchetti O (2010) Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol 48:3510–3516
8. Lehmann LE, Hunfeld KP, Emrich T, Haberhausen G, Wissing H, Hoeft A, Stuber F (2008) A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 197:313–324
9. Bloos F, Hinder F, Becker K, Sachse S, Mekontso DA, Straube E, Cattoir V, Brun-Buisson C, Reinhart K, Peters G, Bauer M (2010) A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med 36:241–247
10. Dark PM, Dean P, Warhurst G (2009) Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit Care 13:217
11. Bloos F, Sachse S, Kortgen A, Pletz MW, Lehmann M, Straube E, Riedemann NC, Reinhart K, Bauer M (2012) Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. PLoS ONE 7:e46003
12. Pletz MW, Wellinghausen N, Welte T (2011) Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view. Intensive Care Med 37:1069–1076
13. Avolio M, Diamante P, Zamparo S, Modolo ML, Grosso S, Zigante P, Tosoni N, De Rosa R, Stano P, Camporese A (2010) Molecular identification of bloodstream pathogens in patients presenting to the emergency department with suspected sepsis. Shock 34:27–30
14. Dierkes C, Ehrenstein B, Siebig S, Linde HJ, Reischl U, Salzberger B (2009) Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 9:126
15. Lehmann LE, Alvarez J, Hunfeld KP, Goglio A, Kost GJ, Louie RF, Raglio A, Regueiro BJ, Wissing H, Stuber F (2009) Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 37:3085–3090
16. Maubon D, Hamidfar-Roy R, Courby S, Vesin A, Maurin M, Pavese P, Ravanel N, Bulabois CE, Brion JP, Pelloux H, Timsit JF (2010) Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect 61:335–342
17. Bravo D, Blanquer J, Tormo M, Aguilar G, Borras R, Solano C, Clari MA, Costa E, Munoz-Cobo B, Argueso M, Pineda JR, Navarro D (2011) Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. Int J Infect Dis 15:e326–e331
18. Grif K, Fille M, Wurzner R, Weiss G, Lorenz I, Gruber G, Eschertzhuber S, Nachbaur D, Lass-Florl C, Orth D (2012) Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsis. Wien Klin Wochenschr 124:266–270
19. Lodes U, Bohmeier B, Lippert H, Konig B, Meyer F (2012) PCR-based rapid sepsis diagnosis effectively guides clinical treatment in patients with new onset of SIRS. Langenbecks Arch Surg 397:447–455
20. Wallet F, Nseir S, Baumann L, Herwegh S, Sendid B, Boulo M, Roussel-Delvallez M, Durocher AV, Courcol RJ (2010) Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 16:774–779
21. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:e56–e93
22. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655
23. Seifert H, Abele-Horn M, Fätkenheuer G, Glück T, Jansen B, Kern W, Mack D, Plum G, Reinert RR, Roos R, Salzberger B, Shah PM, Ullmann U, Weiss M, Welte T, Wisplinghoff H (2007) Part 3: Blutkulturdiagnostik–Sepsis, Endokarditis, Katheterinfektionen. In: Mauch H, Podbielski A, Herrmann M (eds) MIQ: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik, 2nd edn. Elsevier, Urban and Fischer, Munich
24. Becker K, von Eiff C (2011) Staphylococcus, Micrococcus, and other catalase-positive cocci. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (eds) Manual of clinical microbiology, 10th edn. ASM press, Washington, pp 308–330
25. Spellerberg B, Brandt C (2011) Streptococcus. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (eds) Manual of clinical microbiology, 10th edn. ASM press, Washington, pp 331–349
26. Wauters G, Vaneechoutte M (2011) Approaches to the identification of aerobic Gram-negative bacteria. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (eds) Manual of clinical microbiology, 10th edn. ASM press, Washington, pp 539–558
27. Grade Package Insert 04623886001-06. Mannheim, Germany
28. Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van RL, Goessens W, Verbrugh HA, Vos MC (2008) Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 61:428–435
29. Patel R (2013) Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology. Clin Infect Dis 57:564–572
30. Clerc O, Prod’hom G, Vogne C, Bizzini A, Calandra T, Greub G (2013) Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin Infect Dis 56:1101–1107
31. Struelens MJ (2010) Detection of microbial DNAemia: does it matter for sepsis management? Intensive Care Med 36:193–195